Molecular Docking and ADMET Profiling of Novel Human Dipeptidyl Peptidase-IV Inhibitors of Natural Origin from Dalbergia sissoo: In Silico Prediction in Antidiabetic Potential. International Journal of Pharmaceutical Sciences and Drug Research, [S. l.], v. 16, n. 5, p. 841–854, 2024. DOI: 10.25004/IJPSDR.2024.160512. Disponível em: https://ijpsdronline.com/index.php/journal/article/view/9988.. Acesso em: 15 oct. 2025.